Tactive Advisors’s CVS Health CVS Stock Holding History

Tactive Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,580	Closed	-$205K	–	272
2025 Q4	$205K	Buy	+2,580	New	+$203K	0.06%	231

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Tactive Advisors's CVS Position: Q1 2026 in Review

Tactive Advisors sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,580 shares — an estimated $205K sold.

Tactive Advisors first reported a position in CVS in Q4 2025 and held it in 1 quarter. The position peaked at $205K in Q4 2025. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Tactive Advisors reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Tactive Advisors sold 2,580 CVS Health shares in Q1 2026, an estimated $205K.
Tactive Advisors first reported a position in CVS Health in Q4 2025 and held it in 1 quarter.
Tactive Advisors's CVS Health position peaked at $205K in Q4 2025.
1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Tactive Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.